Skip to main content

Lancet study on privatisation in the NHS and treatable deaths

EDM (Early Day Motion) 239: tabled on 30 June 2022

Tabled in the 2022-23 session.

This motion has been signed by 20 Members. It has not yet had any amendments submitted.

Motion text

That this House expresses its concern at analysis published in The Lancet public health journal by the University of Oxford, which finds that the increase in outsourcing to the private for-profit sector in England has corresponded with an increase in the number of patients dying of treatable causes; notes that the analysis shows that an annual increase in outsource spending of 1 per cent is associated with a rise in the number of people dying of treatable causes of 0.38 per cent and that 557 additional deaths between 2014 and 2020 might be attributed to the rise in outsourcing; further notes that the Health and Social Care Act 2012 requires local health bodies to tender services to private health companies; believes that such privatisation and outsourcing has been a disaster for the NHS, which has resulted in falling standards of care for patients, unnecessary deaths and worse working conditions for healthcare staff; calls on the Government to examine the aforementioned analysis; recommends that the Government reverses the outsourcing and privatisation of the NHS in England that has taken place since 2012; and calls on the Government to commit to halting further privatisation in the NHS.

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.

In addition to the sponsors, the following Members have signed to support the motion.

There are no withdrawn signatures for this motion.